跳至主要内容
临床试验/IRCT20170821035831N2
IRCT20170821035831N2已完成未知

?The Evaluatin of Effectiveness of the Milk Testhile for Hepatoxicity in Children with Acute Lymphoblastic Leukemia(ALL)

rmia Medical University0 个研究点目标入组 50 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
30 days 至 15 years(—)
性别
All

入选标准

  • ALL diagnosis based on the criteria of the International Institute of Cancer with initial involvement of more than 20% of bone marrow
  • Hepatotoxicity of Grade 2 and 3 in each of the following four cases based on the criteria of the International Institute of Cancer: Aminoalanine Transferase (ALT); Aspartate Aminotransferase (AST); Total Bilirubin (TB)
  • ALL patients in the chemotherapy maintenance phase.
  • ALL patients, 15-2 years old
  • Patients ALL Pre Bcell, Early Pre Bcell

排除标准

  • Unwillingness to participate in the studyl
  • Extra bile duct obstruction, severe liver or kidney failure, gastrointestinal obstruction, malabsorption syndrome, viral hepatitis
  • Grade 4 hepatotoxicity
  • Sepsis-induced hepatotoxicity
  • Intolerance to Oral Fluoride
  • Deny the patient to study and continue taking the medication
  • No regular and daily intake of medication
  • Gastritis and other complications associated with taking Lourgal
  • History of allergy due to previous use of loroge

研究者

发起方
rmia Medical University

相似试验